Print Page

Products found to contain undeclared medicines

The United States: Public Notification: ABX Weight Loss contains hidden drug ingredient sibutramine
The Food and Drug Administration (FDA) is advising consumers not to purchase or use ABX Weight Loss, a product promoted and sold for weight loss on the Web site,, and possibly in some retail stores.

FDA laboratory analysis confirmed that ABX Weight Loss contains sibutramine. Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.

Please refer to the following website in FDA for details:

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/ Thursday, November 17, 2016
Issued at HKT 16:00